Retinal Vessel Leakage in People With Small Brain Vessel Disease
Uses eye imaging with fluorescent dye to study leaking vessels in small brain vessel disease.
Key facts
- Who runs it
- University of Edinburgh
- Where
- Edinburgh, United KingdomSee the site
- Trial code
- Registry title
- Retinal Vessel Leakage in Cerebral Small Vessel Disease
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 13 Jan 2025
- Expected to end
- 15 Feb 2029
- Type of study
- Observational
- Treatments tested
- Fundus fluorescein angiography, with ultrawide field retinal imaging
- Record updated
- 4 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who already take part in the Mild Stroke Study 3 and have had a recent contrast MRI. It checks for leakage from retinal vessels in cerebral small vessel disease.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Earlier treatment
- People who had treatment for retinal leakage (retinal laser, intravitreal anti-VEGF) cannot join.
Main reasons for not taking part
- Any condition known to cause retinal leakage, such as worse than background diabetic retinopathy or wet age-related macular degeneration
- Previous treatment for retinal leakage (retinal laser, intravitreal anti-VEGF)
- Pregnancy or renal failure
- Known allergy to fluorescein, or a history of allergy such as food or drug induced urticaria or bronchial asthma
- Severe dementia or inability to give informed consent
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Membership in the Mild Stroke Study 3 cohort
- Contrast enhanced MRI within 12 months
- Clear optical media in both eyes, as assessed by study investigator
- Best corrected visual acuity (near vision) ≥N36
Who cannot take part
- Previous treatment for retinal leakage (retinal laser, intravitreal anti-VEGF)
- Recent eye surgery
- Pregnancy, renal failure
- Severe dementia
- Known allergy to fluorescein
- History of allergy such as food or drug induced urticaria or history of bronchial asthma
- Any other severe or acute medical or psychiatric conditions
- Any condition known to cause retinal leakage (i.e., worse than background diabetic retinopathy, retinal vein occlusion, active uveitis, wet age-related macular degeneration, malignant hypertension)
- Shallow anterior chambers as assessed by torch test
- Inability to give informed consent
Where in United Kingdom
- NHS LothianEdinburgh, United KingdomContact: Ian MaccormickTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to learn about leakage from retinal vessels in cerebral small vessel disease. The main questions it aims to answer are:
Read full original descriptionShow less
* Does retinal vessel leakage occur in cerebral small vessel disease? * If it does, is the severity of retinal vessel leakage similar to the severity of cerebral small vessel disease generally?
Participants will be tested using fluorescein angiography. This involves an intravenous injection of fluorescent dye, and is a very sensitive way to find leakage from retinal blood vessels.
Participants will have already had brain scans and other examinations and tests to measure the severity of their cerebral small vessel disease. Our new retinal images will complement the information from these previous tests.
Treatments tested
- Fundus fluorescein angiography, with ultrawide field retinal imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Retinal Vessel Leakage in Cerebral Small Vessel Disease: a Sub-study of the Mild Stroke Study 3
- Plain-language title
- Retinal Vessel Leakage in People With Small Brain Vessel DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 4 March 2026